PATENT CLAIM ANALYSIS

Application Number: 16087557
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-04
Patent Classification: ["424", "489000"]

Abstract:
Provided is a composition which can be utilized for drug delivery systems that can penetrate the blood brain barrier, and has low cytotoxicity. A nanoparticle composition comprises nanoparticles to the surface of which a first substance and a second substance each having specificity to a tumor cell are bound, wherein the first substance having specificity to the tumor cell is a peptide comprising an amino acid sequence of arginine-glycine-aspartic acid, and wherein the second substance having specificity to the tumor cell is an iron-binding protein, and wherein the nanoparticles each comprise an outer layer and vesicles enveloped by the outer layer and the nanoparticles each comprise, as membrane components, a PEGylated phospholipid, a fatty acid with a melting point of 30° C. or more, and a non-PEGylated phospholipid.

Claim (Index 16):
A method for treating cancer, comprising administering the pharmaceutical composition according to  claim 14  to a subject having cancer.

Metadata:
- Claim Count in Document: 13.0
- Percentile: 97.0
- Lexical Diversity: 1.94366
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14215879', '13983750', '14765620', '14599291', '14475708']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7144172990510462
- 35 USC 102 Novelty (BERT): 0.514258864703092
- Combined Prediction Score: 0.6944014556162509
- Mean Citation Score: 243.029726
- Max Citation Score: 256.31534
- Similarity Product: 147.12977201089618

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test